-
Loading metrics
Open Access
Peer-reviewed
Research Article
Common Variation at 1q24.1 (ALDH9A1) Is a Potential Risk Factor for Renal Cancer
-
Marc Y. R. Henrion ,
¶‡ MYRH, MPP, and GS are co-first authors on this work. TE, SC, and RSH are co-last authors on this work.
Affiliation Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom
⨯ -
Mark P. Purdue ,
¶‡ MYRH, MPP, and GS are co-first authors on this work. TE, SC, and RSH are co-last authors on this work.
Affiliation Division of Cancer Epidemiology and Genetics, Department Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America
⨯ -
Ghislaine Scelo ,
¶‡ MYRH, MPP, and GS are co-first authors on this work. TE, SC, and RSH are co-last authors on this work.
Affiliation International Agency for Research on Cancer, Lyon, France
⨯ -
Peter Broderick,
Affiliation Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom
⨯ -
Matthew Frampton,
Affiliation Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom
⨯ -
Alastair Ritchie,
Affiliation MRC Clinical Trials Unit at University College London, Aviation House, London, United Kingdom
⨯ -
Angela Meade,
Affiliation MRC Clinical Trials Unit at University College London, Aviation House, London, United Kingdom
⨯ -
Peng Li,
Affiliation International Agency for Research on Cancer, Lyon, France
⨯ -
James McKay,
Affiliation International Agency for Research on Cancer, Lyon, France
⨯ -
Mattias Johansson,
Affiliation International Agency for Research on Cancer, Lyon, France
⨯ -
Mark Lathrop,
Affiliation McGill University and Genome Quebec Innovation Centre, Montreal, Quebec, Canada
⨯ -
James Larkin,
Affiliation Royal Marsden NHS Foundation Trust, London, United Kingdom
⨯ -
Nathaniel Rothman,
Affiliation Division of Cancer Epidemiology and Genetics, Department Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America
⨯ -
Zhaoming Wang,
Affiliations Division of Cancer Epidemiology and Genetics, Department Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America, Cancer Genomics Research Laboratory, Leidos Biomedical Research Inc., Gaithersburg, Maryland, United States of America
⨯ -
Wong-Ho Chow,
Affiliations Division of Cancer Epidemiology and Genetics, Department Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America, Division of Cancer Prevention and Population Sciences, Department of Epidemiology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America
⨯ -
Victoria L. Stevens,
Affiliation Epidemiology Research Program, American Cancer Society, Atlanta, Georgia, United States of America
⨯ -
W. Ryan Diver,
Affiliation Epidemiology Research Program, American Cancer Society, Atlanta, Georgia, United States of America
⨯ -
Demetrius Albanes,
Affiliation Division of Cancer Epidemiology and Genetics, Department Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America
⨯ -
Jarmo Virtamo,
Affiliation Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland
⨯ -
Paul Brennan,
Affiliation International Agency for Research on Cancer, Lyon, France
⨯ -
Timothy Eisen ,
¶‡ MYRH, MPP, and GS are co-first authors on this work. TE, SC, and RSH are co-last authors on this work.
Affiliation Cambridge University Health Partners, Cambridge, United Kingdom
⨯ -
Stephen Chanock ,
¶‡ MYRH, MPP, and GS are co-first authors on this work. TE, SC, and RSH are co-last authors on this work.
Affiliation Division of Cancer Epidemiology and Genetics, Department Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America
⨯ - [ ... ],
-
Richard S. Houlston
* E-mail: richard.houlston@icr.ac.uk
¶‡ MYRH, MPP, and GS are co-first authors on this work. TE, SC, and RSH are co-last authors on this work.
Affiliation Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom
⨯ - [ view all ]
- [ view less ]
Common Variation at 1q24.1 (ALDH9A1) Is a Potential Risk Factor for Renal Cancer
- Marc Y. R. Henrion,
- Mark P. Purdue,
- Ghislaine Scelo,
- Peter Broderick,
- Matthew Frampton,
- Alastair Ritchie,
- Angela Meade,
- Peng Li,
- James McKay,
- Mattias Johansson
- Published: March 31, 2015
- https://doi.org/10.1371/journal.pone.0122589